Opioid Abuse: White House Expanding Access To Buprenorphine, Naloxone
This article was originally published in The Pink Sheet Daily
Executive Summary
HHS is issuing a proposed rule to increase buprenorphine prescription limit and providing $11m in new funding to states for training and purchase of opioid overdose drug naloxone.
You may also be interested in...
FDA’s Naloxone Product Approval Standards May See Changes
Advisory committees will weigh adequacy of current pharmacokinetic requirements and pediatric dosing for novel formulations of the opioid overdose reversal agent.
Bring Naloxone To Opioid Overdoses: FDA Crowd-Sources Smartphone Apps
FDA announces $40,000 Naloxone App Competition at the start of Prescription Opioid and Heroin Epidemic Awareness Week through Sept. 23, when registration open for the competition, which closes Oct. 7.
Naloxone Costs Could Temper Non-Rx Access Even As Distribution Spreads
CVS in 31 states offers naloxone from pharmacists without a prescription and Walgreens offers it in 14, with plans to more than double the program this year. Whether from pharmacists or OTC, "an affordable price is essential if this is to reach the people who need it," says harm reduction advocate Scott Burris.